Posts Tagged ‘Dutch study’

AUGUST 3: URO TODAY: An understanding of the mechanisms prostate cancer cells use to bypass androgen-deprived conditions, thus moving patients to the hormone refractory stage, is the aim of a new Dutch study. READ MORE>

Knowledge of the molecular and cellular changes that occur during the transition of hormone-naïve to castration-resistant prostate cancer is increasing rapidly. This might provide a window of opportunity for (future) drug development, and for treating patients with these potentially devastating states of disease.

Read Full Post »

JULY 18: URO TODAY: In incontinence treatment called ProACT is a less invasive treatment compared to the standard artificial urinary sphincter, the male sling and bulk injections, a Dutch study shows. READ MORE>

Adjustable Continence Therapy (ProACT™) from Uromedica, Inc, is a minimally invasive urological implant designed to treat male patients who have stress urinary incontinence arising from intrinsic sphincter deficiency following radical prostatectomy for prostate cancer or transurethral resection of the prostate for benign prostatic hyperplasia.

Read Full Post »